First review of MDP via a rather popular request out of the Wolf Den discord for this $101M market cap pharma play trading on the TSX.
Over a one year time frame the stock has performed admirably, up 71%, but if you bought during that early year FOMO run, or participated in their January raise you could be holding some decent sized bags on this one.
Medexus dropped their 2024 annuals last week and the market appears to have had a rather muted reaction, trading down about 7% since. Let’s get into it.